semaglutide risk of cancer GLP-1 drugs and cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like were up to 50% less likely Weight-loss drugs may lower cancer

Trapp S, Stanford SC

These results suggested that GLP-1R activation reduced PFKFB3-driven glycolysis, lactate production and histone lactylation in silica-induced pulmonary fibrosis

Impairment of vesicular ATP release affects glucose metabolism and increases insulin sensitivity

Further investigation of differential gene expression in -1 cells revealed that the most highly upregulated transcripts in response to liraglutide treatment were INS and IAPP (Figure 4, A and B, and Supplemental Figure 4A

Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis

What is the difference between research grade and lab grade KLOW